Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Oncogene

• Publication date

  2017-05-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2016.446PMID 27991922
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton.

  2016cited by this paper
• Rho GTPases, phosphoinositides, and actin

  2014cited by this paper
• Alpha-Smooth Muscle Actin (ACTA2) Is Required for Metastatic Potential of Human Lung Adenocarcinoma

  2013cited by this paper
• Microscopy basics and the study of actin-actin-binding protein interactions.

  2013cited by this paper
• Smooth Muscle α Actin (Acta2) and Myofibroblast Function during Hepatic Wound Healing

  2013cited by this paper
• Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation

  2013cited by this paper
• Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase.

  2012cited by this paper
• Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

  2012cited by this paper
• PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis.

  2012cited by this paper
• Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer.

  2012cited by this paper
• Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.

  2012cited by this paper
• Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1.

  2011cited by this paper
• Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation

  2011cited by this paper
• Regulation of Glycolytic Enzyme Phosphoglycerate Mutase-1 by Sirt1 Protein-mediated Deacetylation♦

  2011cited by this paper
• Open Access RESEARCH

  2010cited by this paper
• An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

  2010cited by this paper
• Mutation of ACTA2 gene as an important cause of familial and nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection (TAAD)

  2009cited by this paper
• The actin cytoskeleton in cancer cell motility

  2009cited by this paper
• Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

  2009cited by this paper
• Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.

  2009cited by this paper
• Tumor cell metabolism: cancer's Achilles' heel.

  2008cited by this paper
• Cancer cell metabolism: Warburg and beyond.

  2008cited by this paper
• Significance of the glycolytic pathway and glycolysis related-genes in tumorigenesis of human colorectal cancers.

  2008cited by this paper
• Mutations in smooth muscle α-actin (ACTA2) lead to thoracic aortic aneurysms and dissections

  2007cited by this paper
• Proteome analysis of human lung squamous carcinoma

  2006cited by this paper
• Identification of differentially expressed, tumor‐associated proteins in oral squamous cell carcinoma by proteomic analysis

  2006cited by this paper
• Rho GTPases: promising cellular targets for novel anticancer drugs.

  2006cited by this paper
• Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling

  2005cited by this paper
• Glycolytic enzymes can modulate cellular life span.

  2005cited by this paper
• Resveratrol-induced cell growth inhibition and apoptosis is associated with modulation of phosphoglycerate mutase B in human prostate cancer cells: two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and mass spectrometry evaluation.

  2004cited by this paper
• Phosphoglycerate Mutase-derived Polypeptide Inhibits Glycolytic Flux and Induces Cell Growth Arrest in Tumor Cell Lines*

  2004cited by this paper
• The actin cytoskeleton in normal and pathological cell motility.

  2004cited by this paper
• Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak.

  2004cited by this paper
• Protein profiles associated with survival in lung adenocarcinoma

  2003cited by this paper
• The NH2-terminal peptide of α–smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo

  2002cited by this paper
• Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma

  1999cited by this paper
• Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and creatine kinase activity and isoenzymes in human brain tumours.

  1997cited by this paper
• The phosphoglycerate mutases.

  1989cited by this paper

• The moonlighting functions of glycolytic enzymes in tumorigenesis

  2026cites this paper
• PGAM1-dependent VDAC1 oligomerization disrupts mitochondrial quality control to drive doxorubicin cardiotoxicity via the cGAS-STING-ferroptosis axis.

  2026cites this paper
• Saturated fatty acid- and/or monounsaturated fatty acid-containing-phosphatidic acids selectively interact with and activate phosphoglycerate mutase 1

  2025cites this paper
• Unveiling Metabolic Signatures as Potential Biomarkers in Common Cancers: Insights from Lung, Breast, Colorectal, Liver, and Gastric Tumours

  2025cites this paper
• Dihydrotanshinone I Targets PGAM1 to Induce SYVN1‐Mediated Ubiquitination and Suppress Glycolysis in Hepatocellular Carcinoma

  2025cites this paper
• Harnessing the role of rubiadin in cancer: Current scenario and future perspectives.

  2025cites this paper
• Metabolic enzyme-associated protein-protein interactions (mPPIs) in cancer: potential vulnerability for cancer treatment?

  2025cites this paper
• Moonlighting functions of glucose metabolic enzymes and metabolites in cancer

  2025cites this paper
• Cell Progression and Survival Functions of Enzymes Secreted in Extracellular Vesicles Associated with Breast and Prostate Cancers

  2025cites this paper
• SEC61G Facilitates Brain Metastases via Antagonizing PGAM1 Ubiquitination and Immune Microenvironment Remodeling in Non-Small Cell Lung Cancer

  2025cites this paper
• PGAM1: a potential therapeutic target mediating Wnt/β-catenin signaling drives breast cancer progression

  2025cites this paper
• REEP6 promotes colorectal cancer glycolysis and tumorigenesis through PRMT5-mediated PGAM1 arginine methylation

  2025cites this paper
• Targeting the Warburg Effect in Cancer: Where Do We Stand?

  2024cites this paper
• O-GlcNAcylation-related genes mediate tumor microenvironment characteristics and prediction of immunotherapy response in gastric cancer

  2024cites this paper
• Insights into Metabolic Reprogramming in Tumor Evolution and Therapy

  2024cites this paper
• Thermal proteome profiling reveals fructose-1,6-bisphosphate as a phosphate donor to activate phosphoglycerate mutase 1

  2024cites this paper
• A phosphoglycerate mutase 1 allosteric inhibitor restrains TAM-mediated colon cancer progression

  2024cites this paper
• PKM2 functions as a histidine kinase to phosphorylate PGAM1 and increase glycolysis shunts in cancer

  2024cites this paper
• Phosphoglycerate mutase 1 promotes breast cancer progression through inducing immunosuppressive M2 macrophages

  2024cites this paper
• Advances in prognostic models for osteosarcoma risk

  2024cites this paper
• Pan-Cancer Analysis of PGAM1 and Its Experimental Validation in Uveal Melanoma Progression

  2024cites this paper
• Identification of human phosphoglycerate mutase 1 (PGAM1) inhibitors using hybrid virtual screening approaches

  2023cites this paper
• RFX6 facilitates aerobic glycolysis‐mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1

  2023cites this paper
• Cellular functions of heat shock protein 20 (HSPB6) in cancer: A review.

  2023cites this paper
• PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 Immunotherapy

  2023cites this paper
• Secretome profiling of Artemisia absinthium extract-loaded polymeric nanoparticle-treated MCF-7 and MDA-MB-231 revealed perturbation in microtubule assembly and cell migration

  2023cites this paper
• The diapause-like colorectal cancer cells induced by SMC4 attenuation are characterized by low proliferation and chemotherapy insensitivity.

  2023cites this paper
• Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1

  2023cites this paper
• A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma.

  2023cites this paper
• The tetrameric structure of Plasmodium falciparum phosphoglycerate mutase is critical for optimal enzymatic activity

  2022cites this paper
• Non-metabolic role of alpha-enolase in virus replication

  2022cites this paper
• Oncometabolism: A Paradigm for the Metabolic Remodeling of the Failing Heart

  2022cites this paper
• Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma

  2022cites this paper
• Targeting PGAM1 in cancer: An emerging therapeutic opportunity.

  2022cites this paper
• Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma.

  2022cites this paper
• Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells

  2022cites this paper
• PGAM1 regulation of ASS1 contributes to the progression of breast cancer through the cAMP/AMPK/CEBPB pathway

  2022cites this paper
• Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways

  2022cites this paper
• Upregulation of miR181a/miR212 Improves Myogenic Commitment in Murine Fusion-Negative Rhabdomyosarcoma

  2021cites this paper
• .EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms to clinical research.

  2021cites this paper
• Phosphoglycerate mutase 1 (PGAM1) overexpression promotes radio- and chemoresistance in gliomas by activating the DNA damage response

  2021cites this paper
• A Schistosoma japonicum MicroRNA Exerts Antitumor Effects Through Inhibition of Both Cell Migration and Angiogenesis by Targeting PGAM1

  2021cites this paper
• In Silico Drug Screening Analysis against the Overexpression of PGAM1 Gene in Different Cancer Treatments

  2021cites this paper
• Ribosome Proteins Represented by RPL27A Mark the Development and Metastasis of Triple-Negative Breast Cancer in Mouse and Human

  2021cites this paper
• Nuclear Pyruvate Kinase M2 (PKM2) Contributes to Phosphoserine Aminotransferase 1 (PSAT1)-Mediated Cell Migration in EGFR-Activated Lung Cancer Cells

  2021cites this paper
• High Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates With Lower Survival

  2021cites this paper
• Site-selective phosphoglycerate mutase 1 acetylation by a small molecule.

  2020cites this paper
• Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer

  2020cites this paper
• Crosstalk between mechanotransduction and metabolism

  2020cites this paper
• Digging deeper through glucose metabolism and its regulators in cancer and metastasis.

  2020cites this paper
• Identification of prognostic biomarkers associated with stromal cell infiltration in muscle‐invasive bladder cancer by bioinformatics analyses

  2020cites this paper
• Sepiapterin reductase: Characteristics and role in diseases

  2020cites this paper
• Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis

  2020cites this paper
• Actin Alpha 2 (ACTA2) Downregulation Inhibits Neural Stem Cell Migration through Rho GTPase Activation

  2020cites this paper
• HKB99, an allosteric inhibitor of phosphoglycerate mutase 1, suppresses invasive pseudopodia formation and upregulates plasminogen activator inhibitor-2 in erlotinib-resistant non-small cell lung cancer cells

  2020cites this paper
• OTT_A_238920 1787..1795

  2020cites this paper
• Sepiapterin reductase promotes hepatocellular carcinoma progression via FoxO3a/Bim signaling in a nonenzymatic manner

  2020cites this paper
• Phosphoglycerate Mutase 1 Activates DNA Damage Repair via Regulation of WIP1 Activity.

  2020cites this paper
• Novel anthraquinone compounds as anticancer agents and their potential mechanism.

  2020cites this paper
• Phosphoglycerate Mutase 1: Its Glycolytic and Non-Glycolytic Roles in Tumor Malignant Behaviors and Potential Therapeutic Significance

  2020cites this paper
• Phosphoglycerate Mutase 1: Its Glycolytic and Non-Glycolytic Roles in Tumor Malignant Behaviors and Potential Therapeutic Signi fi cance

  2020cites this paper
• Phosphoglycerate Mutase 1: Its Glycolytic and Non-Glycolytic Roles in Tumor Malignant Behaviors and Potential Therapeutic Signi fi cance

  2020cites this paper
• mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma

  2019cites this paper
• An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma

  2019cites this paper
• A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer.

  2019cites this paper
• Phosphoglycerate mutase 1 in cancer: A promising target for diagnosis and therapy

  2019cites this paper
• Proteomics Study of Mesenchymal Stem Cell-Like Cells Isolated from Cerebrospinal Fluid of Patients with Meningioma

  2019cites this paper
• Development of Anthraquinone Analogues as Phosphoglycerate Mutase 1 Inhibitors

  2019cites this paper
• Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment.

  2019cites this paper
• PGAM1 knockdown is associated with busulfan-induced hypospermatogenesis and spermatogenic cell apoptosis

  2019cites this paper
• Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications

  2019cites this paper
• OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer

  2019cites this paper
• Identification of antibody reactive proteins in pancreatic cancer using 2D immunoblotting and mass spectrometry.

  2018cites this paper
• S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma

  2018cites this paper
• Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation.

  2018cites this paper
• Phosphoglycerate Mutase 1 Promotes Cell Proliferation and Neuroblast Differentiation in the Dentate Gyrus by Facilitating the Phosphorylation of cAMP Response Element-Binding Protein

  2018cites this paper
• Multiplexed Autoantibody Signature for Serological Detection of Canine Mammary Tumours

  2018cites this paper
• miRNA in a multiomic context for diagnosis, treatment monitoring and personalized management of metastatic breast cancer.

  2018cites this paper
• Transcriptome reprogramming by cancer exosomes: identification of novel molecular targets in matrix and immune modulation

  2018cites this paper
• Identification of PGAM1 as a putative therapeutic target for pancreatic ductal adenocarcinoma metastasis using quantitative proteomics

  2018cites this paper
• Phosphoglycerate Mutase 1 (PGAM1) Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Metastasis by Acting as a Novel Downstream Target of the PI3K/Akt/mTOR Pathway.

  2018cites this paper
• Serum irisin associates with breast cancer to spinal metastasis

  2018cites this paper
• Non-canonical functions of enzymes facilitate cross-talk between cell metabolic and regulatory pathways

  2018cites this paper
• Phosphoglycerate Mutase 1 Predicts the Poor Prognosis of Oral Squamous Cell Carcinoma and is Associated with Cell Migration

  2017cites this paper
• Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1

  2017cites this paper
• Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells

  2017cites this paper
• Hypoxia in the pathogenesis of preeclampsia

  2017cites this paper